Xconomy National

Archives

by in
Entry Author Date Location
Buyouts, Quantified Health, & More San Diego Life Sciences News Bruce V. Bigelow 12/01/11 San Diego
Pfizer Acquires Excaliard, an Isis Spinout With Drug to Fight Excessive Scarring Luke Timmerman 11/22/11 San Diego
Isis Nabs $35M Payment From Glaxo Luke Timmerman 03/31/10 San Diego
Five Biotechnologies That Will Fade Away This Decade Stephen Friend 01/06/10 National
Isis, Genzyme Use Antisense to Go Where Many Drugs Fail—The Brain Luke Timmerman 08/05/09 San Diego
Isis, Alnylam to Collaborate on Single-Stranded RNA Drugs; Deal Could Add Up to $31 Million to Isis’ Coffers Wade Roush 04/29/09 San Diego
Genzyme Places Big Bet on Antisense RNA With Isis Deal Rebecca Zacks 01/08/08 Boston
RNAi Firms Find a New Rival (and Partner) in an Old Technology Malorye Allison 10/04/07 Boston
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.